Company Profile
Advaxis Stock Price, News & Analysis
- Ticker:
- ADXS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for ADXS.
Company overview
Business overview
Advaxis was an immuno-oncology company focused on engineered immune therapies and antigen delivery before its restructuring and public-market decline. Its platform was rooted in cancer immunotherapy.
Geographic Base and Sector Classification
Headquartered in the United States and formerly listed on NASDAQ, Advaxis sat in oncology biotechnology.
Business Model Characteristics
The business depended on clinical development, platform validation, and strategic financing decisions.
Position Within the Biotechnology Landscape
Advaxis belongs to the historical oncology-biotech set rather than the current live public-company universe.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Advaxis do?
Advaxis was an immuno-oncology company focused on engineered immune therapies and antigen delivery before its restructuring and public-market decline. Its platform was rooted in cancer immunotherapy.
On which exchange is ADXS stock listed?
Advaxis (ADXS) is associated with NASDAQ, United States, Biopharma.
What is Advaxis?
Advaxis was an immuno-oncology company focused on engineered immune therapies and antigen delivery before its restructuring and public-market decline.
Which conditions is Advaxis targeting with Advaxis?
Advaxis is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.